Related Experiment Video
Updated: Aug 6, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
The transmembrane domain of the oncogenic mutant ErbB-2 receptor: a structure obtained from site-specific infrared
Andrew J Beevers1, Andreas Kukol
1Department of Biological Sciences, University of Warwick, Coventry CV4 7AL, UK.
Abstract:
ErbB-2 is a member of the family of epidermal growth factor receptors, which shows an oncogenic mutation in the rat gene neu, Val664Glu in the transmembrane domain that causes permanent dimerisation and subsequently leads to uncontrollable cell division and tumour formation. We have obtained the alpha-helical structure of the mutant transmembrane domain dimer experimentally with site-specific infrared dichroism (SSID) based on six transmembrane peptides with 13C18O carbonyl group-labelled residues. The derived orientational data indicate a local helix tilt ranging from 28(+/-6) degrees to 22(+/-4) degrees. Altogether using orientational constraints from SSID and experimental alpha-helical constraints while performing a systematic conformational search including molecular dynamics simulation in a lipid bilayer, we have obtained a unique experimentally defined atomic structure. The resulting structure consists of a right handed alpha-helical bundle with the residues Ile659, Val663, Leu667, Ile671, Val674 and Leu679 in the dimerisation interface. The right-handed bundle is in contrast to the left-handed structures obtained in previous modelling efforts. In order to facilitate tight helical packing, the spacious Glu664 residues do not interact directly but with water molecules that enter the bilayer.
Insights
Researchers determined the atomic structure of the oncogenic ErbB-2 transmembrane domain dimer. This structure reveals a right-handed alpha-helical bundle, crucial for understanding uncontrolled cell division in cancer.
Area of Science:
- Biophysics
- Structural Biology
- Molecular Oncology
Background:
- ErbB-2 (also known as HER2) is an epidermal growth factor receptor.
- An oncogenic mutation (Val664Glu) in the rat neu gene's transmembrane domain causes ErbB-2 dimerization and uncontrolled cell proliferation, leading to tumor formation.
Purpose of the Study:
- To determine the experimentally defined atomic structure of the mutant ErbB-2 transmembrane domain dimer.
- To elucidate the structural basis of permanent dimerization and its role in oncogenesis.
Main Methods:
- Site-specific infrared dichroism (SSID) using 13C18O-labeled transmembrane peptides.
- Experimental determination of alpha-helical constraints and orientational data (helix tilt).
- Conformational search combined with molecular dynamics simulations in a lipid bilayer.
Main Results:
- The study derived the alpha-helical structure of the mutant transmembrane domain dimer.
- SSID data indicated local helix tilt angles ranging from 28° to 22°.
- An experimentally defined atomic structure revealed a right-handed alpha-helical bundle, contrasting with previous left-handed models. Key residues (Ile659, Val663, Leu667, Ile671, Val674, Leu679) form the dimerisation interface.
- Spacious Glu664 residues interact with water, not directly with each other, facilitating tight helical packing.
Conclusions:
- The determined right-handed helical bundle structure provides a precise atomic model for the ErbB-2 transmembrane domain dimer.
- This structure clarifies the mechanism of permanent dimerization and offers insights into ErbB-2-driven oncogenesis.
- Findings contrast with prior computational models and highlight the role of water in stabilizing the dimer interface.
Related Concept Videos
Insertion of Single-pass Transmembrane Proteins in the RER
Integral transmembrane proteins possess transmembrane and extra membrane domains. The transmembrane domains are primarily made of 20-25 hydrophobic amino acids arranged in a helical secondary confirmation. These...
Insertion of Multi-pass Transmembrane Proteins in the RER
The multipass transmembrane proteins are the type IV integral membrane proteins with multiple topogenic sequences determining their spatial arrangement in the ER membrane. Nearly all multipass proteins lack a cleavable signal sequence and use...
Mitogens and the Cell Cycle
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Receptor Tyrosine Kinases
Multi-pass Transmembrane Proteins and β-barrels
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as G-protein-linked receptors (GPCRs) and...

